TY - JOUR
T1 - Antiplatelet effect of cudraxanthone L isolated from Cudrania tricuspidata via inhibition of phosphoproteins
AU - Shin, Jung Hae
AU - Rhee, Man Hee
AU - Kwon, Hyuk Woo
N1 - Publisher Copyright:
© 2020, Korean Society of Pharmacognosy. All rights reserved.
PY - 2020
Y1 - 2020
N2 - Cudrania tricuspidata (C. tricuspidata) is a deciduous tree found in Japan, China and Korea. The root, stems, bark and fruit of C. tricuspidata has been used as traditional herbal remedies such as eczema, mumps, acute arthritis and tuberculosis. In this study, we investigated the potential efficacies of this natural compound by focusing on the inhibitory effect of cudraxanthone L (CXL) isolated from the roots of C. tricuspidata on human platelet aggregation. Our study focused on the action of CXL on collagen-stimulated human platelet aggregation, inhibition of platelet signaling molecules such as fibrinogen binding, intracellular calcium mobilization, fibronectin adhesion, dense granule secretion, and thromboxane A2 secretion. In addition, we investigated the inhibitory effect of CXL on thrombin-induced clot retraction. Our results showed that CXL inhibited collagen-induced human platelet aggregation, intracellular calcium mobilization, fibrinogen binding, fibronectin adhesion and clot retraction without cytotoxicity. Therefore, we confirmed that CXL has inhibitory effects on human platelet activities and has potential value as a natural substance for preventing thrombosis.
AB - Cudrania tricuspidata (C. tricuspidata) is a deciduous tree found in Japan, China and Korea. The root, stems, bark and fruit of C. tricuspidata has been used as traditional herbal remedies such as eczema, mumps, acute arthritis and tuberculosis. In this study, we investigated the potential efficacies of this natural compound by focusing on the inhibitory effect of cudraxanthone L (CXL) isolated from the roots of C. tricuspidata on human platelet aggregation. Our study focused on the action of CXL on collagen-stimulated human platelet aggregation, inhibition of platelet signaling molecules such as fibrinogen binding, intracellular calcium mobilization, fibronectin adhesion, dense granule secretion, and thromboxane A2 secretion. In addition, we investigated the inhibitory effect of CXL on thrombin-induced clot retraction. Our results showed that CXL inhibited collagen-induced human platelet aggregation, intracellular calcium mobilization, fibrinogen binding, fibronectin adhesion and clot retraction without cytotoxicity. Therefore, we confirmed that CXL has inhibitory effects on human platelet activities and has potential value as a natural substance for preventing thrombosis.
KW - Ca mobilization
KW - Clot retraction
KW - Cudraxanthone L
KW - Cyclic adenosine monophosphate
KW - αIIb/Β3 affinity
UR - http://www.scopus.com/inward/record.url?scp=85099537204&partnerID=8YFLogxK
U2 - 10.20307/nps.2020.26.4.295
DO - 10.20307/nps.2020.26.4.295
M3 - Article
AN - SCOPUS:85099537204
SN - 1226-3907
VL - 26
SP - 295
EP - 302
JO - Natural Product Sciences
JF - Natural Product Sciences
IS - 4
ER -